Next Generation News and Research

RSS

New four-way collaboration aims to improve clinical decision-making in the treatment of colon cancer

EKF Diagnostics subsidiary, Selah Genomics, has announced a major, four-way collaboration with Greenville Health System, DecisionQ Corporation, and BD.

From EKF Diagnostics 26 Feb 2015

Three innovative research projects aim to improve lives of people with mobility difficulties

A prosthetic hand controlled by the nervous system, robotic clothing to help people with walking, and biosensors to monitor how patients use equipment or exercise during rehabilitation are the focus of three research projects awarded £5.3 million by the Engineering and Physical Sciences Research Council.

25 Feb 2015

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

Agena Bioscience today released the MassARRAY 24-Well System for mass spectrometry-based genetic analysis, adding to its existing MassARRAY portfolio. The new 24-well format is tailored to smaller clinical testing laboratories requiring modest sample throughput, reduced initial hardware costs, and reduced time to result.

24 Feb 2015

NeoGenomics' revenue increases 36% to $25.0 million in fourth quarter 2014

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter and full year of 2014.

24 Feb 2015

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

Michael M. Halassa, MD, PhD, assistant professor, Departments of Psychiatry and Neuroscience and Physiology at NYU Langone Medical Center's Neuroscience Institute, has been selected as a winner of the 2015 Sloan Research Fellowship.

24 Feb 2015

MRIGlobal awarded contract to develop Sample-to-Sequence system for diagnosis of infectious diseases

MRIGlobal today announced that it has been awarded a $14.8 million contract to develop an end-to-end next generation sequencing system for clinical diagnosis of infectious diseases.

23 Feb 2015

Alfred P. Sloan Foundation announces recipients of 2015 Sloan Research Fellowships

The Alfred P. Sloan Foundation is pleased to announce the selection of 126 outstanding U.S. and Canadian researchers as recipients of the 2015 Sloan Research Fellowships. Awarded annually since 1955, the fellowships honor early-career scientists and scholars whose achievements and potential identify them as rising stars, the next generation of scientific leaders.

23 Feb 2015

University of Tübingen, Mediso partner to develop whole body preclinical PET insert

University of Tübingen and Mediso Ltd announced today at the 4th Tübingen PET/MR Workshop to enter into a collaboration to develop a whole body preclinical PET insert based on silicon photomultiplier sensor technology. This system can be inserted into a high field (7T) preclinical MRI scanner to enable simultaneous PET/MR imaging.

23 Feb 2015

Betaretrovirus may infect patients with primary biliary cirrhosis

In a new study published in Alimentary Pharmacology & Therapeutics, researchers at the University of Alberta's Faculty of Medicine & Dentistry have shown that a betaretrovirus which resembles a mouse mammary tumor virus infects patients with the rare liver disease, primary biliary cirrhosis (PBC).

20 Feb 2015

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

The international outbreak of Ebola in 2014 serves as a reminder for the need to be proactive in preparing for the rapid spread of any newly emerging or re-emerging infectious disease. IDRI today announces it has received $4 million in funding from the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to facilitate pandemic influenza preparedness in developing countries.

19 Feb 2015

New doctorate program to study substance use and related social, health consequences

A new Joint Doctoral Program (JDP) in Interdisciplinary Research on Substance Use has been launched by the Division of Global Public Health in the University of California, San Diego School of Medicine and San Diego State University's School of Social Work. The program will emphasize research devoted to studying the use and misuse of alcohol and drugs - and related social and health consequences.

19 Feb 2015

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand--the first study to demonstrate that a vaccine can protect people from HIV infection.

19 Feb 2015

TB Alliance announces initiation of first human trial of new TB drug candidate

TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB drug candidate to begin a Phase 1 clinical trial since 2009.

19 Feb 2015

Sigma-Aldrich announces release of Next-Gen Sequencing Oligos

Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly.

18 Feb 2015

Caris Life Sciences announces record-setting revenue for 2014

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced select year-end financial and operational results for 2014, which include record-setting revenue and continued case volume growth for its panomic, comprehensive tumor profiling service, Caris Molecular Intelligence.

18 Feb 2015

Cabazitaxel therapy may be more effective in treating prostate cancer

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.

17 Feb 2015

POCARED Diagnostics announces closure of another $15M in funding

POCARED Diagnostics Ltd. is an Israeli-based Diagnostics and Pre-analytical technology manufacturer with offices in the United States announced they have closed another $15 Million in funding.

17 Feb 2015

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

In recent months, several national initiatives for personalized medicine have been announced, including the recently launched precision medicine initiative in the US, driven by rapid advances in genomic technologies and with the promise of cheaper and better healthcare. Significant challenges remain, however, in the management and analysis of genetic information and their integration with patient data.

15 Feb 2015

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.

11 Feb 2015

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.

From Quest Diagnostics 10 Feb 2015

Next Generation News and Research

New four-way collaboration aims to improve clinical decision-making in the treatment of colon cancer

Three innovative research projects aim to improve lives of people with mobility difficulties

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

NeoGenomics' revenue increases 36% to $25.0 million in fourth quarter 2014

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

MRIGlobal awarded contract to develop Sample-to-Sequence system for diagnosis of infectious diseases

Alfred P. Sloan Foundation announces recipients of 2015 Sloan Research Fellowships

University of Tübingen, Mediso partner to develop whole body preclinical PET insert

Betaretrovirus may infect patients with primary biliary cirrhosis

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

New doctorate program to study substance use and related social, health consequences

New clinical trial launched in South Africa to study investigational HIV vaccine regimen

TB Alliance announces initiation of first human trial of new TB drug candidate

Sigma-Aldrich announces release of Next-Gen Sequencing Oligos

Caris Life Sciences announces record-setting revenue for 2014

Cabazitaxel therapy may be more effective in treating prostate cancer

POCARED Diagnostics announces closure of another $15M in funding

A*STAR's GIS scientists develop new system that can predict treatment targets for cancer

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News